Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases

BACKGROUND: Patients with prostate cancer is commonly diagnosed with bone metastases. With the growing use of prostate-specific antigen testing, the frequency of prostate cancer has progressively increased in patients younger than 70 years. Radiotherapy is recognized for its effect on local control...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Bo, Yang, Cheng, He, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847259/
https://www.ncbi.nlm.nih.gov/pubmed/27116938
http://dx.doi.org/10.1186/s12967-016-0868-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847259/
https://www.ncbi.nlm.nih.gov/pubmed/27116938
http://dx.doi.org/10.1186/s12967-016-0868-y

Ejemplares similares